Ok, so unless there is another MAB that has submitted an article to be reviewed, he is talking about us.

That means he knows about us, and that we are in fact in the review period. Fingers crossed that they get the review done quickly.

I think that a positive review will set the stage for everyone to talk openly about Leronlimab with a preface that we expect to have clinical results in a matter of weeks.